| AAV | Adeno-associated virus |
| AIT | Allergen-specific immunotherapy |
| Alum | Aluminum hydroxide |
| APC | Antigen presenting cell |
| cAMP | Cyclic adenosine monophosphate |
| CT | Cholera toxin |
| CNS1 | Non-coding DNA sequence 1 |
| DC | Dendritic cell |
| DAMP | Damage associated molecular pattern |
| GATA3 | GATA binding protein 3 |
| GM-CSF | Granulocyte-macrophage colony-stimulating factor |
| HSC | Hematopoietic stem cells |
| IL(-25) | Interleukin (25) |
| ILC2s | Innate like lymphocytes type II cells |
| iTregs | Induced Tregs |
| LPS | Lipopolysaccharide |
| MAPK | Mitogen-activated protein kinase |
| mMCP1 | Mouse mast cell protease 1 |
| NFκB | Nuclear factor “kapa-light-enhancer“ of activated B cells |
| NOD | Non-obese diabetic |
| Ova | Ovalbumin |
| PBMC | Peripheral blood mononuclear cells |
| SCID | Severe combined immunodeficiency |
| SCF | Stem cell factor |
| SEB | Staphylococcus enterotoxin B |
| TCR | T cell receptor |
| Th1/2/17 | T helper 1/2/17 cell |
| TLR(4) | “Toll“-like receptor (4) |
| (i)Treg | (Peripherally induced) regulatory T cell |
| TSLP | Thymic stromal lymphopoietin |
| WAS(P) | Wiskott-Aldrich syndrome (protein) |